A Case Study on the Application of Disposable Technologies ...
The Use of Disposable Technologies in Antibody ... · The Use of Disposable Technologies in...
Transcript of The Use of Disposable Technologies in Antibody ... · The Use of Disposable Technologies in...
The Use of Disposable Technologies in Antibody Manufacturing Processes
Tim Matthews and Brad Wolk
Process Development EngineeringGenentech, Inc.
South San Francisco, CA
Outline• Rationale for using disposable technologies• Cell Culture applications (bag focus)• Purification applications (bag focus)• Qualification strategy• Case studies
– Disposable bioreactors– Media / Buffer storage in bags– Protein pools in bags– Protein bulk drug substance in bags
• Conclusions
Rationale for Using Disposable Systems
• Technologies can offer economic advantages in:– Operating expense– Capital expenditure– CIP / SIP– Cleaning validation (between runs, between products)– Maintenance (tank inspection, corrosion, etc.)– Installation / implementation time
• Improved aseptic / sterile processing and sampling• Increase plant capacity (turnaround time, space
efficiency)• Consider up-charge on raw materials and disposal costs
Cell Culture Applications
• Disposable Bioreactors up to 500L (or greater) operating volume• Media & nutrient preparation (dissolution) in disposable containers• Sterile storage of media and nutrients in disposable containers up to
2500L• Sterile storage of harvested cell culture fluid in disposable containers
up to 2500L• Sterile sampling• Sterile / Aseptic connecting devices• Harvesting using Disposable Systems – disposable depth filters
Spinners Batch Re-feed Inoculum
Scale-upProduction Harvesting
OperationsHarvested
Culture Fluid
Vial
SampleFeed
Purification Applications
• Buffer preparation (dissolution) in disposable containers• Sterile storage of buffers and protein pools in disposable
containers• Sterile sampling• Aseptic / sterile connecting devices
Protein Load
Load Conditioning
Buffers / Sanitization
solutions
Chromatography and Tangential Flow Filtration Applications
Protein Pools / Bulk Drug Substance
SampleFeed
Qualification of Disposable Systems (Bags)
• General Considerations:– Extractables / Leachables– Vapor Transmission– Integrity / Sterility Validation Testing
• Application Specific:– Sampling– Disposable bioreactors– Buffer / media storage– Protein pools / Bulk Drug Substance storage
• Incorporate new technologies early in development:– R&D production / GLP Toxicology– Early Stage Clinical Production– Late Stage Clinical / Marketed Production
Extractables and Vapor Transmission from Bioprocess Bags using Model Solvents
• Model solvents chosen to mimic aggressive process conditions
• The complete bags were tested as one unit (ports, fittings, tubing, & film)
• High storage temp and hold duration
• Small bags used (maximize surface area to volume)
• Measure extractables– GC/MS, HNMR, TOC,
etc.• Measure weight loss of
liquid (solvent transport through film)
Extracted TOC (PPM) from Bioprocess Bags. Bags stored at 40 degrees Celcius for 180 Days.
0
20
40
60
80
100
120
EVA ULDPE #1 ULDPE #2 LLDPE Glass
Water0.1M Sodium Hydroxide0.1M Phosphoric Acid20X PBS
Solution Flux (cm/day) Through Bag Films at 40oC
0.0E+00
2.0E-04
4.0E-04
6.0E-04
8.0E-04
1.0E-03
1.2E-03
1.4E-03
1.6E-03
1.8E-03
2.0E-03
EVA ULDPE #1 ULDPE #2 LLPE
Water0.1M Sodium Hydroxide0.1M Phosphoric Acid20X PBS50% Methanol
Case Studies Using Disposable Systems
• Disposable bioreactors• Media / buffer bags &
bag containment systems
• Protein Pools in bags• Bulk drug substance in
bags– Shippable bags– Freezable bags
BAG FEATURES
•Sterile
•Mixing
•Sensors (pH, DO, Temp)
•Integrated Volume Measurement
•Sampling
•Transportable
Disposable Bioreactor Technology Choices*
• HyNetics• HyClone• ATMI• LevTech• Xcellerex• Stedim/Applikon• Wave Biotech
– Wave Reactor– FlexMixer
– LevTechATMIHyClone
*Any of these systems could be suitable for solid-liquid dissolution (media or buffer prep) or protein pools
Rocking Motion wave motion
Inflated plastic bag forms a disposable cultivation chamber
Rocking Motion wave motion
Wave action sweeps up cells and prevents settling
Wave action creates large turbulent surface for oxygen transfer
Cell culture media
Courtesy of
Wave Biotech
Oxygen Mass Transfer (kLa) in Wave Bags
• Tests performed with water• kLa increases with angle and rock rate• Operating at 30-50% volume can still achieve kLa’s over
20 h-1
10-L Wave Bag 30% Volume
010203040506070
10 15 20 25 30 35Rock Rate (rock/min)
kLa(
hr-1
)
4 degrees7 degrees10 degrees
10-L Wave Bag 50% Volume
05
101520253035
10 15 20 25 30 35Rock Rate (rock/min)
kLa
(hr-1
)
4 Degrees
7 Degrees
10 Degrees
Wave System1000
Courtesy of
• Evaluated at Genentech for production of monoclonal antibodies in CHO
• 500 liters maximum working volume
• System allows temperature, pH, and dissolved oxygen control
Monoclonal Antibody Production in CHO using Wave System 1000 Bioreactor
%Viable
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Run Time (d)
400L Stirred Tank #1
400L Stirred Tank #2
400L Stirred Tank #3
400L Wave Bag
4L Wave Bag Satellite
Packed Cell Volume Fraction
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Run Time (d)
400L Stirred Tank #1
400L Stirred Tank #2
400L Stirred Tank #3
400L Wave Bag
4L Wave Bag Satellite
Antibody Titer
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Run Time (d)
400L Stirred Tank #1
400L Stirred Tank #2
400L Stirred Tank #3
400L Wave Bag
4L Wave Bag Satellite
• Wave compared side by side with standard 400 liter stirred tank reactor
• High density CHO culture• Operated under Temp, pH, and DO
control.• Wave system showed excellent cell
growth and antibody production characteristics
• Analyses have shown comparable product and impurity profiles
Case Studies Using Disposable Systems
BAG FEATURES
•Sterile
•Mixing
•Sensors (pH, DO, Temp)
•Integrated Volume Measurement
•Sampling
•Transportable
• Disposable bioreactors• Media / buffer bags &
bag containment systems
• Protein Pools in bags• Bulk drug substance in
bags– Shippable bags– Freezable bags
Media / Buffer bag configuration up to 2500 liters*
Vent filter for repeated use
Drain Line to ChromSkid; 1.5”Triclamp / Disposable connector
Fill Line
Sterile Inlet FilterSample bags
Flush Bag
Media /Buffer Bag
*Bags >500L benefit from suspension systems
Buffer Bag Holders• There are several “off
the shelf” choices for basic bag holders
• Containment up to 2500 liters
• Smaller systems are stackable
• Bottom feed for easier access when stacked
• Bottom drain for better liquid recovery & priming
500 Liters200 Liters
Photograph Courtesy of Stedim, LLC website
Bags with In-Line Dilution• Most buffers can be
concentrated >>10-fold• Buffer concentration
allows bags to be used even at very large scale production
• Bags offer corrosion resistance
• Use concentrated buffers in bags then dilute, in-line, to target concentration
• Deliver diluted buffer to unit operations
Buffer concentrates
Blender
Water
ColumnMix
Check
Accept/Reject
Filter
Buffer Prep Filter Buffer Hold Filter Process
Conc. Bag Water Filter Process
Conc. Prep Filter Conc. Hold Water Filter Process
Prep Concentrated Buffer
Buy Concentrated Buffer
Prep Normal-Strength Buffer
Inline Dilution of Buffer Concentrates with Bags
Case Studies Using Disposable Systems
• Disposable bioreactors• Media / buffer bags &
bag containment systems
• Protein Pools in bags• Bulk drug substance in
bags– Shippable bags– Freezable bags
BAG FEATURES
•Sterile
•Mixing
•Sensors (pH, DO, Temp)
•Integrated Volume Measurement
•Sampling
•Transportable
Protein Pools in Bags – Recirculation Mixing Example
PeristalicPump
Flowmeter OD Meter
Injection Port 1000L Buffer Bag• Various mixing technologies
are available: See Disposable Bioreactor technologies
• Allows bags to be used for intermediate protein pool storage
• Liquid – Liquid mixing strategy using bags
• Not as useful for solid – liquid mixing (dissolution).
• Use of standard bag holder and peristaltic pump
• Slight modification to bag to facilitate sterile recirculation path (Aseptic connecting devices / tubing welders)
• Satisfactory mixing was demonstrated even with high viscosity and density differences
1000L Buffer Bag Mixing Studies - 10 LPM (Combined Runs) - 051205
0
1
2
3
4
5
6
0 2 4 6 8 10 12
Time (min)
OD
(Nor
mal
ized
)water / acetone
water / high density dye
1M Na2SO4 / acetone
Case Studies Using Disposable Systems
• Disposable bioreactors• Media / buffer bags &
bag containment systems
• Protein Pools in bags• Bulk drug substance in
bags– Shippable bags– Freezable bags
BAG FEATURES
•Sterile
•Mixing
•Sensors (pH, DO, Temp)
•Integrated Volume Measurement
•Sampling
•Transportation
Bulk Drug Substance in Bags• Bags can be used for longer-term storage of bulks in
bags if product stability permits• Product can be held as liquid (scales up to ~500
liters) or frozen in bags (at smaller scales: up to about 20 liter per bag currently)
• Great care must be taken to ensure bag integrity is maintained
• Convenient format that allows low-cost storage alternative to stainless steel or higher-alloy tanks
• Useful format for shipping to filling sites• Product stability testing must be performed on a
case-by-case basis
Bags for Liquid Bulk Shipment• Reduce dependence on
stainless or higher alloy tanks for storage of protein solutions
• Heavily used for shipment of WFI, media, buffers, serum.
• 500L is typically maximum shipping volume
• Shipping containers have to be economical but extremely robust
• Bag integrity must be maintained – compare to standard tanks
• Economic evaluation should be performed to determine “acceptable” failure rate 1:1,000? 1:10,000?
200L Commercial System
200L System in Envirotainer at Genentech
Freezable Bags for Bulk Storage• Bags can be used for
frozen storage of protein bulks
• Specialty films available• Special containment
systems to protect bag and tubing must be used
• Freezing and thawing rate can be difficult to control
• More useful with small bulks (<20 liters)
• There are commercially available systems for this application
Conclusions• Disposable systems offer many advantages in the
production of monoclonal antibodies in cell culture, purification, and bulk storage areas.
• Product offerings are becoming more comprehensive and can penetrate many areas of clinical and commercial manufacturing facilities
• Current disposable technologies (bags, fittings, filters, connecting devices) are validate-able for use in cGMPproduction of parenteral products
• Disposable probes for bioreactors (pH, DO) need improvement to make useful for the rigors of production environments
• Genentech anticipates future production facilities will be designed around the concept of disposable technologies
Acknowledgements• IBC Coordinators• Genentech
– Donna Giandomenico– Bryan Bean– Kellen Mazzarella– Cell Culture Pilot Plant
• HyClone– Jerry Branscomb– Stephen Twigg
• Stedim– Brent Bushnell– Dave Belomy– Bob Smith-McCollum
• Wave Biotech– Vijay Singh– Scott Westerhout
• XCellerex– Parrish Galliher– Michael Fisher– Susan Dexter